Not applicableStudy completedNCT02111889What this trial is testingTumor Kinase Inhibitor Concentrations Measured by PETWho this might be right forDisseminated Malignant Neoplasm Amsterdam UMC, location VUmc 8
Early research (Phase 1)Looking for participantsNCT05176483What this trial is testingStudy of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid TumorsWho this might be right forRenal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more Exelixis 1,314
Testing effectiveness (Phase 2)Looking for participantsNCT07446855What this trial is testingStudy of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid TumoursWho this might be right forSolid Tumours AstraZeneca 180
Testing effectiveness (Phase 2)Study completedNCT03665285What this trial is testingA Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid TumorsLung CancerBreast Cancer+6 more NextCure, Inc. 109
Testing effectiveness (Phase 2)Study completedNCT05661578What this trial is testingEvaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid TumorsWho this might be right forPD-L1-selected Solid Tumors Hoffmann-La Roche 64
Early research (Phase 1)Active Not RecruitingNCT05339685What this trial is testingBL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid TumorsWho this might be right forBreast Cancer Sichuan Baili Pharmaceutical Co., Ltd. 82
Early research (Phase 1)Not Yet RecruitingNCT06800196What this trial is testingKNT-0916 in Treatment of Unresectable or Metastatic Solid Tumors with FGFR2 AlterationsWho this might be right forSolid Tumors with FGFR2 Alterations, Adult KinoTeck Therapeutics Co., Ltd 151
Early research (Phase 1)Study completedNCT00750425What this trial is testingPhase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid TumoursWho this might be right forAdvanced Solid Tumors AstraZeneca 46
Early research (Phase 1)Study completedNCT02070549What this trial is testingTrametinib in Treating Patients With Advanced Cancer With or Without Hepatic DysfunctionWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Solid Neoplasm+1 more National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320What this trial is testingA Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more Immuneering Corporation 209
Testing effectiveness (Phase 2)Active Not RecruitingNCT05379946What this trial is testingStudy to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid TumorsWho this might be right forSolid Tumor InventisBio Co., Ltd 92
Testing effectiveness (Phase 2)Ended earlyNCT00959946What this trial is testingStudy Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast CancerWho this might be right forAdvanced Breast Cancer (Parts 1 and 2)Advanced Pancreatic Cancer (Part 1)Advanced Colorectal Cancer (Part 1)+2 more Pfizer 32
Early research (Phase 1)Study completedNCT00443976What this trial is testingAurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkins LymphomaUnspecified Adult Solid Tumor, Protocol Specific NCIC Clinical Trials Group 35
Early research (Phase 1)Active Not RecruitingNCT05311397What this trial is testingA166 in Patients With Advanced Solid Malignant TumorsWho this might be right forBreast Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT07605962What this trial is testingPhase 1/2 Study of UI-102 in Selected Advanced CancersWho this might be right forAdvanced Cancer United Immunity, co., Ltd. 140
Testing effectiveness (Phase 2)UnknownNCT05019794What this trial is testingInfigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR AlterationsWho this might be right forGastric CancerGastroesophageal Junction AdenocarcinomaSolid Tumor LianBio LLC 80
Early research (Phase 1)Looking for participantsNCT07524322What this trial is testingStudy of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid TumorsWho this might be right forBreast CancerOvarian CancerEndometrial Cancer+6 more Regor Pharmaceuticals Inc. 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188What this trial is testingStudy of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationWho this might be right forKRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more Novartis Pharmaceuticals 344
Early research (Phase 1)Looking for participantsNCT07260305What this trial is testingA Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor PatientsWho this might be right forAdvanced or Metastatic Solid Tumors Kangabio AUSTRALIA LTD PTY 57
Testing effectiveness (Phase 2)Study completedNCT03523351What this trial is testingStudy of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant PainWho this might be right forMetastatic Solid Tumors of Metastatic Disease Memorial Sloan Kettering Cancer Center 78